KR20220119025A - 매끄러운 표면을 갖는 필름 코팅정 - Google Patents

매끄러운 표면을 갖는 필름 코팅정 Download PDF

Info

Publication number
KR20220119025A
KR20220119025A KR1020227020412A KR20227020412A KR20220119025A KR 20220119025 A KR20220119025 A KR 20220119025A KR 1020227020412 A KR1020227020412 A KR 1020227020412A KR 20227020412 A KR20227020412 A KR 20227020412A KR 20220119025 A KR20220119025 A KR 20220119025A
Authority
KR
South Korea
Prior art keywords
citric acid
tablet
film
weight
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227020412A
Other languages
English (en)
Korean (ko)
Inventor
유리카 오자키
미나코 야마구치
Original Assignee
다이이찌 산쿄 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=76574586&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20220119025(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 다이이찌 산쿄 가부시키가이샤 filed Critical 다이이찌 산쿄 가부시키가이샤
Publication of KR20220119025A publication Critical patent/KR20220119025A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020227020412A 2019-12-23 2020-12-18 매끄러운 표면을 갖는 필름 코팅정 Pending KR20220119025A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019231824 2019-12-23
JPJP-P-2019-231824 2019-12-23
PCT/JP2020/047412 WO2021132072A1 (ja) 2019-12-23 2020-12-18 滑らかな表面を有するフィルムコーティング錠

Publications (1)

Publication Number Publication Date
KR20220119025A true KR20220119025A (ko) 2022-08-26

Family

ID=76574586

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227020412A Pending KR20220119025A (ko) 2019-12-23 2020-12-18 매끄러운 표면을 갖는 필름 코팅정

Country Status (10)

Country Link
US (1) US20230081350A1 (https=)
EP (1) EP4082536B1 (https=)
JP (1) JP6993765B2 (https=)
KR (1) KR20220119025A (https=)
CN (1) CN114786653B (https=)
BR (1) BR112022012382A2 (https=)
CA (1) CA3162615C (https=)
ES (1) ES3025936T3 (https=)
TW (1) TWI820372B (https=)
WO (1) WO2021132072A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024248079A1 (https=) * 2023-06-02 2024-12-05

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150079166A1 (en) 2013-04-04 2015-03-19 Daiichi Sankyo Company, Limited Solid Compositions Comprising a Salt of Aminocarboxylic Acid
US20180042878A1 (en) 2015-03-19 2018-02-15 Daiichi Sankyo Company, Limited Solid preparation including antioxidant
US20180243223A1 (en) 2015-03-19 2018-08-30 Daiichi Sankyo Company, Limited Solid preparation including colorant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5883616A (ja) * 1981-11-12 1983-05-19 Asahi Kogyo Kk 塩分補給用錠剤の製造方法
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
WO2011081118A1 (ja) * 2009-12-29 2011-07-07 興和株式会社 経口投与用医薬組成物
JP6349306B2 (ja) * 2013-04-25 2018-06-27 杏林製薬株式会社 錠剤
BR112021001008A2 (pt) * 2018-07-30 2021-04-20 Daiichi Sankyo Company, Limited comprimido de fármaco
US20200246317A1 (en) * 2019-02-01 2020-08-06 Cersci Therapeutics, Inc. Methods of treating diabetic neuropathy with a thiazoline anti-hyperalgesic agent
CN110538153B (zh) * 2019-09-26 2022-04-26 扬子江药业集团四川海蓉药业有限公司 一种高稳定性、快速释放的固体制剂及其制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150079166A1 (en) 2013-04-04 2015-03-19 Daiichi Sankyo Company, Limited Solid Compositions Comprising a Salt of Aminocarboxylic Acid
US20180042878A1 (en) 2015-03-19 2018-02-15 Daiichi Sankyo Company, Limited Solid preparation including antioxidant
US20180243223A1 (en) 2015-03-19 2018-08-30 Daiichi Sankyo Company, Limited Solid preparation including colorant

Also Published As

Publication number Publication date
JPWO2021132072A1 (https=) 2021-07-01
JP6993765B2 (ja) 2022-02-07
TWI820372B (zh) 2023-11-01
TW202135793A (zh) 2021-10-01
ES3025936T3 (en) 2025-06-10
WO2021132072A1 (ja) 2021-07-01
CN114786653A (zh) 2022-07-22
CA3162615C (en) 2024-01-16
CN114786653B (zh) 2023-10-31
EP4082536B1 (en) 2025-04-09
BR112022012382A2 (pt) 2022-08-30
EP4082536A1 (en) 2022-11-02
US20230081350A1 (en) 2023-03-16
EP4082536A4 (en) 2024-01-24
CA3162615A1 (en) 2021-07-01

Similar Documents

Publication Publication Date Title
JP6630344B2 (ja) 着色剤を含有する固形製剤
JP7744908B2 (ja) ミロガバリンベシル酸塩を含有する口腔内崩壊錠
JP4572300B2 (ja) ピモベンダン経口投与製剤
JP2021028326A (ja) レベチラセタムを含む錠剤
KR20220119025A (ko) 매끄러운 표면을 갖는 필름 코팅정
JP2020090471A (ja) アジルサルタン及びアムロジピンを含有する医薬組成物及びその製造方法
JP7264711B2 (ja) レベチラセタム含有医薬組成物の製造方法
JP2024067030A (ja) ミラベグロン含有放出制御医薬組成物及びその製造方法
JP4963846B2 (ja) 口腔内崩壊錠及びその製造方法
JP2016155777A (ja) モンテルカスト又はその塩を含む組成物
JP6439503B2 (ja) 固形製剤
JP4572296B2 (ja) ピモベンダン経口投与製剤
TWI536992B (zh) And a medicinal composition for oral administration of improved elution and / or absorption
JP2020090470A (ja) アジルサルタン及びアムロジピンを含有する医薬組成物及びその製造方法
HK40078891B (en) Film-coated tablets having smooth surface
HK40078891A (en) Film-coated tablets having smooth surface
JP2015193611A (ja) 安定な固形医薬組成物
JP2018080119A (ja) 医薬組成物におけるアジルサルタンの速やかな溶出性を維持し、かつ安定化する方法
JP2022104836A (ja) エゼチミブ及びロスバスタチンを含む錠剤
JP2025022654A (ja) プラスグレル含有医薬組成物
HK40003924A (en) Solid preparation containing colorant
HK40003924B (en) Solid preparation containing colorant
WO2018079734A1 (ja) メマンチンまたはその薬学上許容される塩を含有する医薬組成物
JP2018016609A (ja) バゼドキシフェン酢酸塩を含む固形製剤及びその製造方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902